Display options
Share it on

J Oral Maxillofac Pathol. 2013 Jan;17(1):61-4. doi: 10.4103/0973-029X.110731.

Fluorescence in-situ hybridization technique as a diagnostic and prognostic tool in oral squamous cell carcinoma.

Journal of oral and maxillofacial pathology : JOMFP

Pm Sunil, Cr Ramachandran, S Gokul, N Jaisanghar

Affiliations

  1. Department of Oral and Maxillofacial Pathology, Rajah Mutiah Dental College, Chidambaram, Tamil Nadu, India.

PMID: 23798832 PMCID: PMC3687191 DOI: 10.4103/0973-029X.110731

Abstract

BACKGROUND AND OBJECTIVES: Early diagnosis and appropriate management are of prime importance for oral squamous cell carcinoma (OSCC) in the present scenario. Molecular changes in OSCC are well documented with the occurrence of a wide range of genetic damage. Identification of the genetic damage in OSCC using various diagnostic aids is mandatory, and one of the important advances in this field is cytogenetics using fluorescence in-situ hybridization (FISH). The aim of the present study is to analyze the genetic alteration in OSCC using FISH as a diagnostic aid.

MATERIALS AND METHODS: Peripheral blood was analyzed in 20 clinically and histopathologically proven OSCC cases and 10 healthy controls for chromosomal alteration under standardized conditions.

RESULTS: Of the 20 OSCC cases, 7 (35%) cases showed chromosomal alterations. No cases from the control group showed any chromosomal changes. Of the positive cases in OSCC, 30% cases showed increased copy number of cyclin D1 gene and 1 (5%) case showed positivity indicating extra copy of chromosome 11p11.11-q11 region.

INTERPRETATION AND CONCLUSION: Increased genetic damage in OSCC which is a prominent feature can be identified by the use of FISH as seen from the present study. The findings suggest that FISH can be used as a diagnostic aid in the detection of genetic changes occurring in OSCC. The present study also suggests the importance of peripheral blood as a medium for assessing cytogenetic damage in OSCC.

Keywords: Fluorescence in-situ hybridization; cyclin D1; oral squamous cell carcinoma; peripheral blood

References

  1. Anticancer Res. 1999 Mar-Apr;19(2A):925-31 - PubMed
  2. Clin Cancer Res. 1997 Sep;3(9):1609-14 - PubMed
  3. Clin Cancer Res. 2004 Oct 15;10(20):6897-904 - PubMed
  4. Genes Chromosomes Cancer. 1996 Jul;16(3):155-63 - PubMed
  5. Eur J Cancer. 1997 Nov;33(13):2203-10 - PubMed
  6. Am J Med Genet. 2002 Oct 30;115(3):118-24 - PubMed
  7. Br J Oral Maxillofac Surg. 1998 Aug;36(4):252-60 - PubMed
  8. Int J Oncol. 2002 Mar;20(3):623-30 - PubMed
  9. Int J Oncol. 1998 May;12(5):1151-5 - PubMed
  10. Science. 1996 Dec 6;274(5293):1672-7 - PubMed
  11. Cancer Res. 1996 Dec 1;56(23):5325-9 - PubMed
  12. Expert Rev Mol Diagn. 2004 Jan;4(1):71-81 - PubMed
  13. Hum Genet. 1991 Nov;88(1):39-41 - PubMed
  14. Proc Natl Acad Sci U S A. 2000 Jan 4;97(1):303-8 - PubMed
  15. Clin Genet. 2001 Feb;59(2):65-73 - PubMed
  16. Cancer. 2002 Nov 15;95(10):2152-9 - PubMed
  17. Oncologist. 2003;8(1):45-58 - PubMed

Publication Types